臨床研究等提出・公開システム

Date of registration	Aug. 02, 2010
Last modified on	Dec. 17, 2018
Trial ID	jRCT2080221174

Scientific Title	GSK2132231A Antigen-Specific Cancer Immunotherapeutic as adjuvant therapy in patients with resected melanoma
Public Title

Contact for Scientific Queries	Name
	Contact Name for Scientific Queries
	Address
	Phone Number
	E-mail Address

Contact for Public Queries	Name
	Contact Name for Public Queries	GlaxoSmithKline K.K.
	Address	http://glaxosmithkline.co.jp/legal/japic.html
	Phone Number
	E-mail Address

Recruitment Status

Date of First Enrolment
Target Sample Size
Study Type		Interventional
Study Design	Study Design	Refer to 'GSK Clinical Study Register'
Study Design	Objective
Phase		N/A
Key inclusion & exclusion criteria	Inclusion Criteria	Refer to 'GSK Clinical Study Register'
	Exclusion Criteria	Refer to 'GSK Clinical Study Register'
	Minimum Age	No limit
	Maximum Age	No limit
	Gender	Both
Health Condition or Problem Studied		melanoma
Intervention(s)		investigational material(s) Generic name etc : GSK2132231A INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : intramuscular injection
Health Condition(s) Keyword
Intervention(s) Keyword
Health Condition(s) Code
Intervention(s) Code
Primary Outcome		Refer to 'GSK Clinical Study Register' Refer to 'GSK Clinical Study Register'
Secondary Outcome		Refer to 'GSK Clinical Study Register' Refer to 'GSK Clinical Study Register'

Primary Sponsor	GlaxoSmithKline K.K.
Secondary Sponsor

Name of Funding Organization
Name of Research Funding

Name of IRB
Address of IRB
Phone Number of IRB
E-mail Address of IRB
Status of IRB Review
Date of Approval by IRB

Secondary ID No.	JapicCTI-101211
Name of Other Registries

Countries / Regions of Recruitment

History of Changes

No	Publication date
10	Dec. 17, 2018	(this page)	Changes
9	Mar. 29, 2018	Detail	Changes
8	Mar. 13, 2018	Detail	Changes
7	Nov. 28, 2017	Detail	Changes
6	Dec. 03, 2014	Detail	Changes
5	Aug. 22, 2014	Detail	Changes
4	Oct. 18, 2011	Detail	Changes
3	Oct. 18, 2011	Detail	Changes
2	Aug. 02, 2010	Detail	Changes
1	Aug. 02, 2010	Detail

List of change history